283 related articles for article (PubMed ID: 28726173)
1. Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
Zanello M; Roux A; Ursu R; Peeters S; Bauchet L; Noel G; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Emery E; Petit A; Peltier J; Voirin J; Caire F; Barat JL; Vignes JR; Menei P; Langlois O; Dezamis E; Carpentier A; Dam Hieu P; Metellus P; Pallud J;
J Neurooncol; 2017 Nov; 135(2):285-297. PubMed ID: 28726173
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.
Zhang C; Wang X; Hao S; Su Z; Zhang P; Li Y; Song G; Yu L; Wang J; Ji N; Xie J; Gao Z
World Neurosurg; 2016 Nov; 95():77-84. PubMed ID: 27485530
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.
Audureau E; Chivet A; Ursu R; Corns R; Metellus P; Noel G; Zouaoui S; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Petit A; Emery E; Lechapt-Zalcman E; Peltier J; Duntze J; Dezamis E; Voirin J; Menei P; Caire F; Dam Hieu P; Barat JL; Langlois O; Vignes JR; Fabbro-Peray P; Riondel A; Sorbets E; Zanello M; Roux A; Carpentier A; Bauchet L; Pallud J;
J Neurooncol; 2018 Feb; 136(3):565-576. PubMed ID: 29159777
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
6. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
[TBL] [Abstract][Full Text] [Related]
7. Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
Roux A; Peeters S; Zanello M; Bou Nassif R; Abi Lahoud G; Dezamis E; Parraga E; Lechapt-Zalcmann E; Dhermain F; Dumont S; Louvel G; Chretien F; Sauvageon X; Devaux B; Oppenheim C; Pallud J
J Neurooncol; 2017 Oct; 135(1):83-92. PubMed ID: 28669011
[TBL] [Abstract][Full Text] [Related]
8. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
[TBL] [Abstract][Full Text] [Related]
9. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
[TBL] [Abstract][Full Text] [Related]
11. Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
Bertaut A; Truntzer C; Madkouri R; Kaderbhai CG; Derangère V; Vincent J; Chauffert B; Aubriot-Lorton MH; Farah W; Mourier KL; Boidot R; Ghiringhelli F
Oncotarget; 2016 Oct; 7(43):70948-70958. PubMed ID: 27487142
[TBL] [Abstract][Full Text] [Related]
12. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.
Uzuka T; Aoki H; Natsumeda M; Takahashi H; Fujii Y
Neurol Med Chir (Tokyo); 2012; 52(8):570-6. PubMed ID: 22976140
[TBL] [Abstract][Full Text] [Related]
14. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
15. Survival and functional status after resection of recurrent glioblastoma multiforme.
Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
Lee J; Ahn SS; Chang JH; Suh CO
Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
[TBL] [Abstract][Full Text] [Related]
17. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.
Sacko A; Hou MM; Temgoua M; Alkhafaji A; Marantidou A; Belin C; Mandonnet E; Ursu R; Doridam J; Coman I; Levy-Piedbois C; Carpentier AF
J Neurooncol; 2015 May; 122(3):567-73. PubMed ID: 25700836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
